Equasens

  • Market Cap: N/A
  • Industry: Software Products
  • ISIN: FR0012882389
EUR
43.50
0.35 (0.81%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROE of 22.81%

 
2

Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 49.83

 
3

Healthy long term growth as Net Sales has grown by an annual rate of 7.08%

 
4

Flat results in Dec 24

5

With ROE of 0.00%, it has a Fair valuation with a 2.70 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

EUR 634 Million ()

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

14.97%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.75

Revenue and Profits:
Net Sales:
29 Million
(Quarterly Results - Dec 2012)
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.12%
0%
0.12%
6 Months
-12.65%
0%
-12.65%
1 Year
3.69%
0%
3.69%
2 Years
-24.61%
0%
-24.61%
3 Years
-41.77%
0%
-41.77%
4 Years
-49.12%
0%
-49.12%
5 Years
-55.38%
0%
-55.38%

Equasens for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
7.08%
EBIT Growth (5y)
0.96%
EBIT to Interest (avg)
49.83
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.84
Tax Ratio
20.21%
Dividend Payout Ratio
51.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
27.43%
ROE (avg)
22.81%
Valuation key factors
Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
2.70
EV to EBIT
NA
EV to EBITDA
EV to Capital Employed
3.05
EV to Sales
10.83
PEG Ratio
NA
Dividend Yield
15.28%
ROCE (Latest)
ROE (Latest)
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Equasens"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.36% vs 2.66% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -22.70% vs 0.62% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "216.80",
          "val2": "219.80",
          "chgp": "-1.36%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "59.40",
          "val2": "68.60",
          "chgp": "-13.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.70",
          "chgp": "57.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.00",
          "val2": "-0.90",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.80",
          "val2": "48.90",
          "chgp": "-22.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "205.90%",
          "val2": "252.10%",
          "chgp": "-4.62%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
216.80
219.80
-1.36%
Operating Profit (PBDIT) excl Other Income
59.40
68.60
-13.41%
Interest
1.10
0.70
57.14%
Exceptional Items
-1.00
-0.90
-11.11%
Consolidate Net Profit
37.80
48.90
-22.70%
Operating Profit Margin (Excl OI)
205.90%
252.10%
-4.62%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -1.36% vs 2.66% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -22.70% vs 0.62% in Dec 2023

stock-summaryCompany CV
About Equasens stock-summary
stock-summary
Equasens
Software Products
Pharmagest Interactive SA is a France-based company that develops and integrates management software packages for drugstores. The Company is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. It operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
Company Coordinates stock-summary
Company Details
5 allee de Saint-Cloud, Bp 117 , VILLERS LES NANCY None : 54600
stock-summary
Tel: 33 8 2090810033 03 83159067
stock-summary
Registrar Details